Pretest - Tumor Board Tuesday - October 26, 2021 (ID: i788-21)

1.Please list your first name, last name, and email:(Required.)
2.What is your specialty?(Required.)
3.How many patients with non-metastatic gastric cancer do you treat each week?(Required.)
4.According to NCCN guidelines which of the following procedures or tests should be considered for a clinical T3 non-metastatic gastric cancer fit for surgery?(Required.)
5.Among larger perioperative and/or adjuvant gastroesophageal cancer trials how frequently is dMMR/MSI-H observed?(Required.)